Advances in the Treatment of Chronic Myeloid Leukemia

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with chronic myeloid leukemia (CML) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with chronic myeloid leukemia (CML) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Identify response assessment and management of tyrosine kinase inhibitor resistance in the treatment of CMLCite the time-based response milestones and monitoring in patients with CMLUnderstand the concept of treatment-free remission after discontinuing nilotinib or dasatinib in patients with chronic-phase philadelphia chromosome–positive CML

---

Write the first review

Resource tags